{"entity":{"type":"insider","cik":"0001709976","url":"/insider/0001709976","json_url":"/insider/0001709976.json","name":"Gallagher Brian M. Jr.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2017-07-06","last":"2022-06-27","span_basis":"filed_date"},"name_variants":[{"name":"Gallagher Brian M. Jr.","source":"filing","n_filings":3,"first_seen":"2017-07-06","last_seen":"2022-06-27"}],"transactions":[{"id":6824544,"accession":"0001209191-22-039356","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-039356","line_url":"/filing/0001209191-22-039356#line-1","is_derivative":false,"issuer_cik":"0001709976","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001709976","owner_cik":"0001709976","owner_name":"Gallagher Brian M. Jr.","owner_url":"/insider/0001709976","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":1.59,"price_display":"1.59","price_state":"stated","total_value":47700.0,"total_display":"47,700.00","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-23","filed_date":"2022-06-27","scope":"insider"},{"id":6569021,"accession":"0000899243-18-019455","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-18-019455","line_url":"/filing/0000899243-18-019455#line-4","is_derivative":false,"issuer_cik":"0001693415","issuer_name":"Translate Bio, Inc.","issuer_ticker":"TBIO","issuer_name_source":null,"issuer_url":"/issuer/0001693415","owner_cik":"0001709976","owner_name":"Gallagher Brian M. Jr.","owner_url":"/insider/0001709976","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":269230.0,"shares_display":"269,230","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":3499990.0,"total_display":"3,499,990.00","shares_owned_after":3697912.0,"shares_owned_after_display":"3,697,912","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-07-02","filed_date":"2018-07-05","scope":"insider"},{"id":4729803,"accession":"0000899243-17-018014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-018014","line_url":"/filing/0000899243-17-018014#line-2","is_derivative":false,"issuer_cik":"0001420565","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001420565","owner_cik":"0001709976","owner_name":"Gallagher Brian M. Jr.","owner_url":"/insider/0001709976","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":273333.0,"shares_display":"273,333","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":4099995.0,"total_display":"4,099,995.00","shares_owned_after":1431519.0,"shares_owned_after_display":"1,431,519","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-07-05","filed_date":"2017-07-06","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001828522","name":"eFFECTOR Therapeutics, Inc.","url":"/issuer/0001828522","role":"Director","n_filings":1,"first_seen":"2022-06-27","last_seen":"2022-06-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001693415","name":"Translate Bio, Inc.","url":"/issuer/0001693415","role":"Director","n_filings":1,"first_seen":"2018-07-05","last_seen":"2018-07-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001420565","name":"AILERON THERAPEUTICS INC","url":"/issuer/0001420565","role":"Director","n_filings":1,"first_seen":"2017-07-06","last_seen":"2017-07-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001709976","retrieved_at":"2026-08-21T10:10:10+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}